PDM-35

2-Phenyl-3,5-dimethylmorpholine is a drug with stimulant and anorectic effects, related to phenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.[1]

3,5-dimethyl-2-phenylmorpholine (PDM-35)
Legal status
Legal status
  • CA: Unscheduled
  • DE: NpSG (Industrial and scientific use only)
  • UK: Under Psychoactive Substances Act
  • US: Analogue to a Schedule I/II drug (possibly, in some states)
Identifiers
IUPAC name
  • 3,5-dimethyl-2-phenylmorpholine
CAS Number
PubChem CID
DrugBank
UNII
  Provide&page2=PDM-35 (verify)

See also

References
  1. HU 219458, Boswell GE, Kelley JL, Mehta NB, "2-phenyl-3,5-dimethyl morpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them.", published 28 April 2001, assigned to Wellcome Foundation Ltd.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.